Results 221 to 230 of about 391,673 (354)

Targeted Delivery of Exosome-Derived miRNA-185-5p Inhibitor via Liposomes Alleviates Apoptosis and Cuproptosis in Dilated Cardiomyopathy

open access: yesInternational Journal of Nanomedicine
Shuai Xu,1– 5,* Yiyao Zeng,1,2,* Xin Tan,1,2 Ge Zhang,3– 5 Anchen Xu,1,2 Huimin Fan,6 Fengyi Yu,7 Zhen Qin,3– 5 Yahui Song,6 Yufeng Jiang,1,2 Xiangyu Wang,1,2 Duoduo Zhang,8 Yuxin Nong,1,2 Dede Lian,9 Junnan Tang,3– 5 Yafeng Zhou1,2 ...
Xu S   +15 more
doaj  

Transcaval Transcatheter Aortic Valve Replacement: Clinical Outcomes From a TAVI Program Without Prior Transcaval Experience

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Despite the emergence of the transcaval (TCv) access route for transcatheter aortic valve implantation (TAVI) in the treatment of patients with hostile iliofemoral anatomy, the number of patients reported in clinical series of TCv TAVI has been relatively small (< 500 published cases). We assessed procedural and clinical outcomes in
Conor J. Doyle   +6 more
wiley   +1 more source

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology

open access: yesJournal of Nuclear Cardiology, 2018
R. Slart   +16 more
semanticscholar   +1 more source

Breaking the Barrier: Unraveling the No‐Reflow Phenomenon in Cardiovascular Medicine

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The no‐reflow phenomenon is a stubborn and often devastating complication in cardiovascular medicine, where blood flow is restored to an artery, yet the microvasculature remains unresponsive. First identified in 1967, this phenomenon has haunted clinicians and researchers alike, particularly in the context of acute myocardial infarction (AMI).
Stephanie Howes   +9 more
wiley   +1 more source

Transcatheter Aortic Valve Implantation in a Ross Procedure Patient With Severe Autograft Regurgitation: A Case Report

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy